1.
LeBlanc R, Hollmann S, Tay J. CANADIAN COST ANALYSIS COMPARING MAINTENANCE THERAPY WITH BORTEZOMIB VERSUS LENALIDOMIDE FOR PATIENTS WITH MULTIPLE MYELOMA POST AUTOLOGOUS STEM CELL TRANSPLANT. J Popl Ther Clin Pharmacol [Internet]. 2018 Nov. 5 [cited 2022 Aug. 8];23(1). Available from: https://jptcp.com/index.php/jptcp/article/view/237